Healthcare & Medical

Wharton Biotech Conference 2026

The Wharton Biotech Conference 2026, presented by Penn Biotech Group, brings together industry leaders, professionals, and students to connect the Philadelphia biotech ecosystem. The event covers a broad range of topics including translational science, business and capital, AI's impact on drug development, commercialization, policy, workforce, and investment…

Visit the official site
7Speakers
7Sponsors
1Sessions
13Companies · in total

Speakers

Programmed at Wharton, in alphabetical order.

Ben Doranz
President & CEO · Integral Molecular
Christopher Pettigrew
Senior Director, Business Development (Global Corporate Development), GSK · GSK
David Baker
Head of Corporate Development, Nospharma; Board Director at GRI Bio and Devonian Health Group; Member of Robinhood Ventures · Nospharma / GRI Bio / Devonian Health Group / Robinhood Ventures
Pan Pan
Senior Vice President, Business Development, OncoC4 · OncoC4
Shivani Kadiyala
PBG Co-VP of Case Competition · Penn Biotech Group
Tiffany Wilson
President & CEO · Science Center
Tran Nguyen
Global Head Business Development & Licensing Finance at Novartis · Novartis

Sponsors

The companies behind the program. Tiers as disclosed.

Basis Health
BioBuzz
GSEG
Penn Law
Penn SP2
Science Center
Venture Lab

Agenda

Selected from 1 sessions.

  • 2:30 PM

    Business & Capital: The Art of Business Development. From Collaboration to Acquisition.

Company intelligence

What does it mean when 13 companies show up, and 1 bet on three roles at once?

Thirteen companies. one are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
1All threespeak · spons · exh
6Sponsoringsponsor only
6Speakingspeaker only

In all three roles

Science Center

Speakers by seniority

86% of the speakers carry senior titles: C-suite, Founder, VP, or Director-level.

  • C-suite229%
  • VP-level229%
  • Director / Head of229%
  • Other roles114%

Of 7 speakers · classified by free-text title

Most-represented companies
Sponsors by tier
unspecified7
100% of 7